Biocon Adjusts Evaluation Amid Mixed Financial Signals and Growth Challenges

Aug 05 2025 08:12 AM IST
share
Share Via
Biocon has recently adjusted its evaluation, reflecting changes in the stock's technical landscape. Key financial metrics indicate efficient inventory management and strong operating profit coverage. However, the company faces challenges with a high debt to EBITDA ratio and modest long-term growth, while institutional holdings remain significant.
Biocon, a prominent player in the Pharmaceuticals & Biotechnology sector, has recently undergone an adjustment in its evaluation. This revision reflects a shift in the technical landscape surrounding the stock, with indicators suggesting a transition from a bullish to a mildly bullish stance.

Key financial metrics reveal that Biocon's inventory turnover ratio stands at a notable 3.05 times, indicating efficient management of inventory. The operating profit to interest ratio is also strong at 5.08 times, showcasing the company's ability to cover its interest obligations. In the latest quarter, Biocon reported a profit after tax of Rs 325.25 crore, marking a significant growth of 69% compared to the previous four-quarter average.

Despite these positive indicators, the company faces challenges, including a high debt to EBITDA ratio of 3.23 times, which raises concerns about its ability to service debt. Over the past year, while the stock has delivered a return of 7.37%, profits have experienced a decline of 7.3%. Additionally, the company's long-term growth has been modest, with operating profit growing at an annual rate of 6.63% over the last five years.

With high institutional holdings at 28.86%, Biocon's stock remains under scrutiny as it navigates these mixed signals in its financial landscape.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News